- Home
- ARBB vs MYNZ Comparison
ARBB vs MYNZ Comparison
Compare ARBB & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- MYNZ
- Stock Information
- Founded
- ARBB 1997
- MYNZ 2021
- Country
- ARBB Singapore
- MYNZ Germany
- Employees
- ARBB N/A
- MYNZ N/A
- Industry
- ARBB EDP Services
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- ARBB Technology
- MYNZ Health Care
- Exchange
- ARBB Nasdaq
- MYNZ Nasdaq
- Market Cap
- ARBB 12.3M
- MYNZ 11.2M
- IPO Year
- ARBB 2023
- MYNZ 2021
- Fundamental
- Price
- ARBB $0.41
- MYNZ $6.53
- Analyst Decision
- ARBB
- MYNZ Hold
- Analyst Count
- ARBB 0
- MYNZ 2
- Target Price
- ARBB N/A
- MYNZ N/A
- AVG Volume (30 Days)
- ARBB 141.6K
- MYNZ 1.6M
- Earning Date
- ARBB 11-22-2024
- MYNZ 10-21-2024
- Dividend Yield
- ARBB N/A
- MYNZ N/A
- EPS Growth
- ARBB N/A
- MYNZ N/A
- EPS
- ARBB N/A
- MYNZ N/A
- Revenue
- ARBB $12,334,474.00
- MYNZ $917,203.00
- Revenue This Year
- ARBB N/A
- MYNZ $21.95
- Revenue Next Year
- ARBB N/A
- MYNZ $30.77
- P/E Ratio
- ARBB N/A
- MYNZ N/A
- Revenue Growth
- ARBB N/A
- MYNZ 16.23
- 52 Week Low
- ARBB $0.22
- MYNZ $0.18
- 52 Week High
- ARBB $4.55
- MYNZ $7.95
- Technical
- Relative Strength Index (RSI)
- ARBB 40.44
- MYNZ 59.79
- Support Level
- ARBB $0.47
- MYNZ $3.65
- Resistance Level
- ARBB $0.50
- MYNZ $7.95
- Average True Range (ATR)
- ARBB 0.05
- MYNZ 0.95
- MACD
- ARBB -0.01
- MYNZ -0.18
- Stochastic Oscillator
- ARBB 12.42
- MYNZ 59.07
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT') and Investment holding and others. It earns its maximum profit from the Internet of Things segment.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.